recent articles

Visiopharm are pleased to announce the novel launch of an automated, and IVDR certified, AI-driven digital pathology workflow for University Medical Center Utrecht (UMCU) in the Netherlands. The workflow will be based on existing and new next...

Visiopharm’s quantitative image analysis software suite uniquely offers a secure, scalable, agnostic platform that helps pathologists and researchers alike address the quality and cost challenges in drug discovery and cancer...

Hørsholm, Denmark, May 3rd - Visiopharm A/S announces the first result of their multifaceted strategy to apply Deep Learning technologies to its leading image analysis solution for cancer research and diagnostics. Visiopharm considers Deep...

OR

platinum partners

gold partners

Silver Partners

Media Partners